PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase

Sancak, Yasemin, Thoreen, Carson C., Peterson, Timothy R., Lindquist, Robert A., Kang, Seong A., Spooner, Eric, Carr, Steven A., Sabatini, David M.·2007·Molecular Cell

Cited by (1,000)

Items 201–300 of 1,000

  1. Mechanisms of mTOR inhibitor resistance in cancer therapy
    Jennifer S. Carew, Kevin R. Kelly, Steffan T. Nawrocki · 2011 · Targeted Oncology
  2. Akt-dependent Activation of mTORC1 Complex Involves Phosphorylation of mTOR (Mammalian Target of Rapamycin) by IκB Kinase α (IKKα)
    Han C. Dan, Aaron Ebbs, Manolis Pasparakis, Terry Van Dyke, Daniela S. Daniela Sanchez Bassères, Albert S. Baldwin · 2014 · Journal of Biological Chemistry
  3. Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives
    Pei Shi Ong, Louis Z. Wang, Xiaoyun Dai, Sheng Hsuan Tseng, Shang Jun Loo, Gautam Sethi · 2016 · Frontiers in Pharmacology
  4. The role of mTOR in the management of solid tumors: An overview
    Alexios S Strimpakos, Eleni M. Karapanagiotou, M. W. Saif, Kostas Syrigos · 2008 · Cancer Treatment Reviews
  5. Structure-Activity Analysis of Niclosamide Reveals Potential Role for Cytoplasmic pH in Control of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling
    Bruno D. Fonseca, Graham H. Diering, Michael Bidinosti, Kush Dalal, Tommy Alain, Aruna D. Balgi, Roberto Forestieri, Matt Nodwell, Charles Vincent Rajadurai, Cynthia Gunaratnam et al. · 2012 · Journal of Biological Chemistry
  6. The evolution of the TOR pathway and its role in cancer
    Elspeth M. Beauchamp, Leonidas C. Platanias · 2012 · Oncogene
  7. Regulation of autophagy by protein post-translational modification
    Willayat Yousuf Wani, Michaël Boyer‐Guittaut, Matthew B. Dodson, John C. Chatham, Victor M. Darley-Usmar, Jianhua Zhang · 2014 · Laboratory Investigation
  8. Redox Regulates Mammalian Target of Rapamycin Complex 1 (mTORC1) Activity by Modulating the TSC1/TSC2-Rheb GTPase Pathway
    Sei Yoshida, Sungki Hong, Tsukasa Suzuki, Shigeyuki Nada, Aristotle M. Mannan, Junying Wang, Masato Okada, Kun‐Liang Guan, Ken Inoki · 2011 · Journal of Biological Chemistry
  9. Rictor is a novel target of p70 S6 kinase-1
    Caroline Treins, Patricia H. Warne, Mark A. Magnuson, Mario Pende, Julian Downward · 2009 · Oncogene
  10. mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression
    Tobias Bruno Huber, Gerd Walz, E. Wolfgang Kuehn · 2010 · Kidney International
  11. Autophagy as a target for cancer therapy: new developments
    Steffan T. Nawrocki, Carew, K. Kelly · 2012 · Cancer Management and Research
  12. Homeostatic functions of the p53 tumor suppressor: Regulation of energy metabolism and antioxidant defense
    Ivan A. Olovnikov, Julia E. Kravchenko, Peter M. Chumakov · 2008 · Seminars in Cancer Biology
  13. mTORC1 pathway in DNA damage response.
    Yin-Xing Ma, Y. Vassetzky, Svetlana Dokudovskaya · 2018 · Biochimica et biophysica acta. Molecular cell research
  14. Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins
    L Liu, L Chen, Jun Chung, Shile Huang · 2008 · Oncogene
  15. Proline-rich Akt substrate of 40 kDa (PRAS40): A novel downstream target of PI3k/Akt signaling pathway
    Haitao Wang, Qishan Zhang, Qiang Jeremy Wen, Yongxin Zheng, Philip Lazarovici, Hao Jiang, Jun Lin, Wenhua Zheng · 2011 · Cellular Signalling
  16. What a Tangled Web We Weave: Emerging Resistance Mechanisms to Inhibition of the Phosphoinositide 3-Kinase Pathway
    Klempner, Samuel J., Myers, Andrea P., Cantley, Lewis C. · 2013 · Cancer Discovery
  17. Therapeutic Targeting of Autophagy
    Amabel M. Orogo, Åsa B. Gustafsson · 2015 · Circulation Research
  18. The immunobiology of mTOR in autoimmunity
    Suto, Takahito, Karonitsch, Thomas · 2020 · Journal of Autoimmunity
  19. mTOR links oncogenic signaling to tumor cell metabolism
    Yecies, Jessica L., Manning, Brendan D. · 2011 · Journal of Molecular Medicine
  20. Regulation of mTORC1 by the Rab and Arf GTPases
    Li Li, Eunjung Kim, Hai‐Xin Yuan, Ken Inoki, Pankuri Goraksha-Hicks, Rachel L. Schiesher, Thomas P. Neufeld, Kun‐Liang Guan · 2010 · Journal of Biological Chemistry
  21. Mammalian Target of Rapamycin: Hitting the Bull′s‐Eye for Neurological Disorders
    Zhao Zhong Chong, Yan Shang, Lijie Zhang, Shaohui Wang, Kenneth Maiese · 2010 · Oxidative Medicine and Cellular Longevity
  22. G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling
    Mirja Tamara Prentzell, Ulrike Rehbein, Marti Cadena Sandoval, Ann‐Sofie De Meulemeester, Ralf Baumeister, Laura Brohée, Bianca Berdel, Mathias Bockwoldt, Bernadette Carroll, Suvagata Roy Chowdhury et al. · 2021 · Cell
  23. The 14-3-3 proteins in regulation of cellular metabolism
    Rune Kleppe, Aurora Martı́nez, Stein Ove Døskeland, Jan Haavik · 2011 · Seminars in Cell and Developmental Biology
  24. The Complexes of Mammalian Target of Rapamycin
    Hongyu Zhou, Shile Huang · 2010 · Current Protein and Peptide Science
  25. Overview of Research into mTOR Inhibitors
    Beibei Mao, Qi Zhang, Li Ma, Dongsheng Zhao, Pan Zhao, Peizheng Yan · 2022 · Molecules
  26. Protein kinase B: signalling roles and therapeutic targeting
    Elizabeth M. Sale, Graham J. Sale · 2007 · Cellular and Molecular Life Sciences
  27. MAPK/ERK Signaling Regulates Insulin Sensitivity to Control Glucose Metabolism in Drosophila
    Wei Zhang, Barry J. Thompson, Ville Hietakangas, Stephen Michael Cohen · 2011 · PLoS Genetics
  28. mTORC1 signaling: what we still don't know
    Xuemin Wang, Christopher G. Proud · 2010 · Journal of Molecular Cell Biology
  29. IL-15–PI3K–AKT–mTOR: A Critical Pathway in the Life Journey of Natural Killer Cells
    Alaa Kassim Ali, Neethi Nandagopal, Seung‐Hwan Lee · 2015 · Frontiers in Immunology
  30. Targeting Cullin-RING ligases by MLN4924 induces autophagy via modulating the HIF1-REDD1-TSC1-mTORC1-DEPTOR axis
    Yongchao Zhao, Xiufang Xiong, Lijun Jia, Yi Sun · 2012 · Cell Death and Disease
  31. The PTEN–AKT3 signaling cascade as a therapeutic target in melanoma
    SubbaRao V. Madhunapantula, Gavin P. Robertson · 2009 · Pigment Cell & Melanoma Research
  32. A Dynamic Network Model of mTOR Signaling Reveals TSC-Independent mTORC2 Regulation
    Piero Dalle Pezze, Annika Sonntag, Antje Thien, Mirja Tamara Prentzell, Markus Gödel, Sven Fischer, Elke Neumann‐Haefelin, Tobias Bruno Huber, Ralf Baumeister, Daryl P. Shanley et al. · 2012 · Science Signaling
  33. Rapamycin Inhibits Cytoskeleton Reorganization and Cell Motility by Suppressing RhoA Expression and Activity
    Lei Liu, Yan Luo, Long Chen, Tao Shen, Baoshan Xu, Wenxing Chen, Hongyu Zhou, Xiuzhen Han, Shile Huang · 2010 · Journal of Biological Chemistry
  34. mTOR Cross-Talk in Cancer and Potential for Combination Therapy
    Fabiana Conciatori, Ludovica Ciuffreda, Chiara Bazzichetto, Italia Falcone, Sara Pilotto, Emilio Bria, Francesco Cognetti, Michèle Milella · 2018 · Cancers
  35. Activation of autophagy rescues synaptic and cognitive deficits in fragile X mice
    Jingqi Yan, Morgan W. Porch, Brenda L. Court-Vazquez, Michael V. L. Bennett, Ruth Suzanne Zukin · 2018 · Proceedings of the National Academy of Sciences
  36. Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease
    Qiannan Ren, Qiming Sun, Junfen Fu · 2023 · Autophagy
  37. The Opposing Actions of Target of Rapamycin and AMP-Activated Protein Kinase in Cell Growth Control
    Sravanth Kumar Hindupur, Asier González, Michael N. Hall · 2015 · Cold Spring Harbor Perspectives in Biology
  38. Optimal dietary protein level improved growth, disease resistance, intestinal immune and physical barrier function of young grass carp (Ctenopharyngodon idella)
    Jing Xu, Pei Wu, Wei‐Dan Jiang, Yang Liu, Jun Jiang, Sheng‐Yao Kuang, Ling Tang, Wu‐Neng Tang, Yong‐An Zhang, Xiao‐Qiu Zhou et al. · 2016 · Fish & Shellfish Immunology
  39. mTOR signaling for biological control and cancer
    Anya Alayev, Marina K. Holz · 2013 · Journal of Cellular Physiology
  40. PIM1 Protein Kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells
    Fengxue Zhang, Zanna M. Beharry, Thurl E. Harris, Michael B. Lilly, Charles D. Smith, Sandeep Mahajan, Andrew S. Kraft · 2009 · Cancer Biology & Therapy
  41. Interactions among mTORC, AMPK and SIRT: a computational model for cell energy balance and metabolism
    Mehrshad Sadria, Anita T. Layton · 2021 · Cell Communication and Signaling
  42. Alleviation of neuronal energy deficiency by mTOR inhibition as a treatment for mitochondria-related neurodegeneration
    Xinde Zheng, Leah F. Boyer, Mingji Jin, Yongsung Kim, Weiwei Fan, Cédric Bardy, W. Travis Berggren, Ronald M. Evans, Fred H. Gage, Tony R. Hunter · 2016 · eLife
  43. mTOR: A Cellular Regulator Interface in Health and Disease
    Fahd Boutouja, Christian M. Stiehm, Harald W. Platta · 2019 · Cells
  44. The Role of mTORC1 in Regulating Protein Synthesis and Skeletal Muscle Mass in Response to Various Mechanical Stimuli
    Craig A. Goodman · 2013 · Reviews of physiology, biochemistry and pharmacology
  45. Triptolide Restores Autophagy to Alleviate Diabetic Renal Fibrosis through the miR-141-3p/PTEN/Akt/mTOR Pathway
    Li, Xiao-yu, Wang, Shan-shan, Han, Zhe, Han, Fei, Chang, Yun-peng, Yang, Yang, Xue, Mei, Sun, Bei, Chen, Li-ming · 2017 · Molecular Therapy - Nucleic Acids
  46. Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer
    Feigin, Michael E., Akshinthala, S. Dipikaa, Araki, Kiyomi, Rosenberg, Avi Z., Muthuswamy, Lakshmi B., Martin, Bernard, Lehmann, Brian D., Berman, Hal K., Pietenpol, Jennifer A., Cardiff, Robert D. et al. · 2014 · Cancer Research
  47. Olfactory receptor OR2AT4 regulates human hair growth
    Jérémy Chéret, Marta Bertolini, Leslie Ponce, Janin Lehmann, Teresa Tsai, Majid Ali Alam, Hanns H. Hatt, Ralf Paus · 2018 · Nature Communications
  48. Roles of mTOR Signaling in Tissue Regeneration
    Xiangyong Wei, Lingfei Luo, Jin-Zi Chen · 2019 · Cells
  49. Amino Acid Signaling to MTOR Mediated by Inositol Polyphosphate Multikinase
    Kim, Seyun, Kim, Sangwon F., Maag, David, Maxwell, Micah J., Resnick, Adam C., Juluri, Krishna R., Chakraborty, Anutosh, Koldobskiy, Michael A., Cha, Seung Hun, Barrow, Roxanne et al. · 2011 · Cell Metabolism
  50. Phosphatidic Acid Activates Mammalian Target of Rapamycin Complex 1 (mTORC1) Kinase by Displacing FK506 Binding Protein 38 (FKBP38) and Exerting an Allosteric Effect
    Mee‐Sup Yoon, Yuting Sun, Edwin J. Arauz, Yu Jiang, Jie Chen · 2011 · Journal of Biological Chemistry
  51. New Insights into Protein Kinase B/Akt Signaling: Role of Localized Akt Activation and Compartment-Specific Target Proteins for the Cellular Radiation Response
    Klaudia Szymonowicz, Sebastian Oeck, Nathalie M. Malewicz, Verena Jendrossek · 2018 · Cancers
  52. Role of mTORC1 in mechanically induced increases in translation and skeletal muscle mass
    Goodman, Craig A. · 2019 · Journal of Applied Physiology
  53. AMPK and Raptor: Matching Cell Growth to Energy Supply
    David Grahame Hardie · 2008 · Molecular Cell
  54. The Systemic Control of Growth
    Laura Boulan, Marco Milán, Pierre Léopold · 2015 · Cold Spring Harbor Perspectives in Biology
  55. Mutation of the PDK1 PH Domain Inhibits Protein Kinase B/Akt, Leading to Small Size and Insulin Resistance
    José Ramón Bayascas, Stephan Wullschleger, Kei Sakamoto, Juan Manuel García‐Martínez, Carol Clacher, David Komander, Daan M. F. van Aalten, Krishna Murthy Boini, Florian J.W. Lang, Christopher Lipina et al. · 2008 · Molecular and Cellular Biology
  56. An emerging role for TOR signaling in mammalian tissue and stem cell physiology
    Ryan Charles Russell, Chong Fang, Kun‐Liang Guan · 2011 · Development
  57. The Hippo pathway integrates PI3K–Akt signals with mechanical and polarity cues to control tissue growth
    Nerea Borreguero-Muñoz, Georgina Fletcher, Mario Aguilar‐Aragon, Ahmed Elbediwy, Zoé I. Vincent‐Mistiaen, Barry J. Thompson · 2019 · PLoS Biology
  58. Pyruvate Kinase M2 Activates mTORC1 by Phosphorylating AKT1S1
    Chang-Liang He, Yangyang Bian, Yu Xue, Zexian Liu, Kai-Qiang Zhou, Cui-Fang Yao, Yan Lin, Han-Fa Zou, Fang-Xiu Luo, Yuan-Yuan Qu et al. · 2016 · Scientific Reports
  59. Evolutionary Conservation of the Components in the TOR Signaling Pathways
    Hisashi Tatebe, Kazuhiro Shiozaki · 2017 · Biomolecules
  60. The mammalian target of rapamycin-signaling pathway in regulating metabolism and growth1,2
    X. Yang, C.B. Yang, A. Farberman, Todd Christopher Rideout, C. F. M. de Lange, J. France, Ming Z. Fan · 2007 · Journal of Animal Science
  61. Rheb1 Is Required for mTORC1 and Myelination in Postnatal Brain Development
    Jia Zou, Liang Zhou, Xiao-Xia Du, Yi-Fei Ji, Jia Xu, Junlong Tian, Wanxiang Jiang, Yi Zou, Shouyang Yu, Lingxue Gan et al. · 2011 · Developmental Cell
  62. ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity
    Cinthia Silva-Vilches, Sabine Ring, Karsten Mahnke · 2018 · Frontiers in Immunology
  63. Cell Cycle Regulation by the Nutrient-Sensing Mammalian Target of Rapamycin (mTOR) Pathway
    Elisabet Cuyàs, Bruna Corominas-Faja, Jorge Joven, Javier Abel Menéndez · 2014 · Methods in molecular biology
  64. Nutrient availability and lactogenic hormones regulate mammary protein synthesis through the mammalian target of rapamycin signaling pathway
    Sergio A. Burgos, M. Dai, John P. Cant · 2010 · Journal of Dairy Science
  65. The Multifaceted Role of Nutrient Sensing and mTORC1 Signaling in Physiology and Aging
    Stephanie Fernandes, Constantinos Demetriades · 2021 · Frontiers in Aging
  66. P2X7 Integrates PI3K/AKT and AMPK-PRAS40-mTOR Signaling Pathways to Mediate Tumor Cell Death
    Bian Shu, Xiaofeng Sun, Aiping Bai, Chunqing Zhang, Linglin Li, Keiichi Enjyoji, Wolfgang Georg JUNGER, Simon Christopher Robson, Yan Wu · 2013 · PLoS ONE
  67. Mechanisms of Kaempferol in the treatment of diabetes: A comprehensive and latest review
    Yan Yang, Zhengtao Chen, Xiaoyan Zhao, Hongyan Xie, Lian Du, Hong Li Gao, Chunguang Xie · 2022 · Frontiers in Endocrinology
  68. The splicing-factor oncoprotein SF2/ASF activates mTORC1
    Rotem Karni, Yoshitaka Hippo, Scott W. Lowe, Adrian R. Krainer · 2008 · Proceedings of the National Academy of Sciences
  69. mTOR Kinase Domain Phosphorylation Promotes mTORC1 Signaling, Cell Growth, and Cell Cycle Progression
    Bilgen Ekim Üstünel, Brian Magnuson, Hugo A. Acosta-Jaquez, Jennifer A. Keller, Edward P. Feener, Diane C. Fingar · 2011 · Molecular and Cellular Biology
  70. The kinase triad, AMPK, mTORC1 and ULK1, maintains energy and nutrient homoeostasis
    Elaine A. Dunlop, Andrew R. Tee · 2013 · Biochemical Society Transactions
  71. A Critical Kinase Cascade In Neurological Disorders: Pi3K, Akt and Mtor
    Zhao Zhong Chong, Yan Shang, Shaohui Wang, Kenneth Maiese · 2012 · Future Neurology
  72. mTor Signaling in Skeletal Muscle During Sepsis and Inflammation: Where Does It All Go Wrong?
    Robert A. Frost, Charles H. Lang · 2011 · Physiology
  73. Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies
    Jorge Alberto Garcia, David Danielpour · 2008 · Molecular Cancer Therapeutics
  74. Key factors in mTOR regulation
    Xiaochun Bai, Yu Jiang · 2009 · Cellular and Molecular Life Sciences
  75. TGFβ-Stimulated MicroRNA-21 Utilizes PTEN to Orchestrate AKT/mTORC1 Signaling for Mesangial Cell Hypertrophy and Matrix Expansion
    Nirmalya Dey, Nandini Ghosh‐Choudhury, Balakuntalam S. Kasinath, Goutam Ghosh Choudhury · 2012 · PLoS ONE
  76. Noncanonical Pathway for Regulation of CCL2 Expression by an mTORC1-FOXK1 Axis Promotes Recruitment of Tumor-Associated Macrophages
    Hirokazu Nakatsumi, Masaki Matsumoto, Keiichi I. Nakayama · 2017 · Cell Reports
  77. Mammalian Target of Rapamycin Complex 1 (mTORC1) Activity Is Associated with Phosphorylation of Raptor by mTOR
    Lifu Wang, John C. Lawrence, Thomas Wayne Sturgill, Thurl E. Harris · 2009 · Journal of Biological Chemistry
  78. m6A mRNA methylation-directed myeloid cell activation controls progression of NAFLD and obesity
    Yanqin Qin, Binghua Li, Suyavaran Arumugam, Qiuxia Lu, Salah M. Mankash, Junzi Li, Beicheng Sun, Jiansheng Li, Richard Anthony Flavell, Huabing Li et al. · 2021 · Cell Reports
  79. TOR signaling never gets old: Aging, longevity and TORC1 activity
    Daniel S. Evans, Pankaj Kapahi, Wen‐Chi Hsueh, Lutz Kockel · 2010 · Ageing Research Reviews
  80. Metabolic benefits of resistance training and fast glycolytic skeletal muscle
    Nathan K. LeBrasseur, Kenneth X. Walsh, Zoltan Pierre Arany · 2010 · American Journal of Physiology-Endocrinology and Metabolism
  81. Human protein–protein interaction networks and the value for drug discovery
    Heinz Ruffner, Andreas Bauer, Tewis Bouwmeester · 2007 · Drug Discovery Today
  82. Autophagy in Locomotor Muscles of Patients with Chronic Obstructive Pulmonary Disease
    Guo, Yeting, Gosker, Harry R., Schols, Annemie M. W. J., Kapchinsky, Sophia, Bourbeau, Jean, Sandri, Marco, Jagoe, R. Thomas, Debigaré, Richard, Maltais, François, Taivassalo, Tanja et al. · 2013 · American Journal of Respiratory and Critical Care Medicine
  83. Therapeutic targeting of the mTOR ‐signalling pathway in cancer: benefits and limitations
    Michele Moschetta, Antonia Reale, Carolina Marasco, Angelo Vacca, Maria Rosaria Carratù · 2014 · British Journal of Pharmacology
  84. Mechanistic Target of Rapamycin Complex 2 Protects the Heart From Ischemic Damage
    Mirko Völkers, Mathias H. Konstandin, Shirin Doroudgar, Haruhiro Toko, Pearl J. Quijada, Shabana Din, Anya Y. Joyo, Luis Ornelas, Kaitleen Samse, Donna J. Thuerauf et al. · 2013 · Circulation
  85. Dual function of the PI3K-Akt-mTORC1 axis in myelination of the peripheral nervous system
    Gianluca Figlia, Camilla Norrmén, Jorge A. Pereira, Daniel Gerber, Ueli Suter · 2017 · eLife
  86. Current development of the second generation of mTOR inhibitors as anticancer agents
    Hongyu Zhou, Shile Huang · 2011 · 癌症:英文版
  87. Concurrent resistance and aerobic exercise stimulates both myofibrillar and mitochondrial protein synthesis in sedentary middle-aged men
    Cheyne E. Donges, Nicholas A. Burd, Rob Duffield, Greg C. Smith, Daniel W. D. West, Michael J. Short, Richard Mackenzie, Lindsay Dudley Plank, Peter Robin Shepherd, Stuart M. Phillips et al. · 2012 · Journal of Applied Physiology
  88. An overview of rapamycin: from discovery to future perspectives
    Young Ji Yoo, Hanseong Kim, Sung Ryeol Park, Yeo Joon Yoon · 2016 · Journal of Industrial Microbiology & Biotechnology
  89. Macropinocytosis, mTORC1 and cellular growth control
    Yoshida, Sei, Pacitto, Regina, Inoki, Ken, Swanson, Joel · 2018 · Cellular and Molecular Life Sciences
  90. SKIP‐HOPS recruits TBC1D15 for a Rab7‐to‐Arl8b identity switch to control late endosome transport
    Marlieke L.M. Jongsma, Jeroen Bakker, Birol Cabukusta, Nalan Liv, Daphne M. van Elsland, Job Fermie, Jimmy J.L.L. Akkermans, Coenraad P. Kuijl, Sabina Y. van der Zanden, Lennert Janssen et al. · 2020 · The EMBO Journal
  91. REDD1 deletion prevents dexamethasone-induced skeletal muscle atrophy
    Florian Alexis Britto, Gwénaëlle Begue, Bernadette Rossano, Aurélie Docquier, Barbara Vernus, Chamroeun Sar, Arnaud Ferry, Anne Bonnieu, Vincent Ollendorff, François B. Favier · 2014 · American Journal of Physiology-Endocrinology and Metabolism
  92. Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity
    Sarah Christine Elisabeth Wright, Natali Vasilevski, Violeta Serra, Jordi Ahnert Rodon, Pieter J.A. Eichhorn · 2021 · Cancers
  93. Nutrient-sensing mTORC1: Integration of metabolic and autophagic signals
    Valerie P. Tan, Shigeki Miyamoto · 2016 · Journal of Molecular and Cellular Cardiology
  94. The spectrum of neurodevelopmental, neuromuscular and neurodegenerative disorders due to defective autophagy
    Celine Deneubourg, Mauricio Ramm, Luke J. Smith, Olga Baron, Kritarth Singh, Susan Byrne, Michael R. Duchen, Mathias Gautel, Eeva‐Liisa Eskelinen, Manolis Fanto et al. · 2021 · Autophagy
  95. Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting
    Shweta Bisht, Manisha Nigam, Shyam Singh Kunjwal, Sergey Plygun, Abhay Prakash Mishra, Javad Sharifi‐Rad · 2022 · Stem Cells International
  96. Growth control via TOR kinase signaling, an intracellular sensor of amino acid and energy availability, with crosstalk potential to proline metabolism
    Xin‐Hua Liao, Amit R. Majithia, Xiuli Huang, Alan R. Kimmel · 2008 · Amino Acids
  97. Selective Activation of mTORC1 Signaling Recapitulates Microcephaly, Tuberous Sclerosis, and Neurodegenerative Diseases
    Kassai, Hidetoshi, Sugaya, Yuki, Noda, Shoko, Nakao, Kazuki, Maeda, Tatsuya, Kano, Masanobu, Aiba, Atsu · 2014 · Cell Reports
  98. A Cell-Autonomous Signature of Dysregulated Protein Phosphorylation Underlies Muscle Insulin Resistance in Type 2 Diabetes
    Thiago M. Batista, Ashok Kumar Jayavelu, Nicolai J. Wewer Albrechtsen, Salvatore Iovino, Jasmin Lebastchi, Hui Pan, Jonathan M. Dreyfuss, Anna Krook, Juleen Rae Zierath, Matthias Mann et al. · 2020 · Cell Metabolism
  99. mTOR, AMPK, and Sirt1: Key Players in Metabolic Stress Management
    Silvia Cetrullo, Stefania D’Adamo, Benedetta Tantini, Rosa Maria Borzı̀, Flavio Flamigni · 2015 · Critical Reviews in Eukaryotic Gene Expression
  100. Mechanisms of amino acid sensing in mTOR signaling pathway
    Eunjung Kim · 2009 · Nutrition Research and Practice